 Cell Survival
"Cell Survival" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
| Descriptor ID |
D002470
|
| MeSH Number(s) |
G04.299.316
|
| Concept/Terms |
Cell Survival- Cell Survival
- Survival, Cell
- Cell Viability
- Cell Viabilities
- Viabilities, Cell
- Viability, Cell
|
Below are MeSH descriptors whose meaning is more general than "Cell Survival".
Below are MeSH descriptors whose meaning is more specific than "Cell Survival".
This graph shows the total number of publications written about "Cell Survival" by people in this website by year, and whether "Cell Survival" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1981 | 0 | 1 | 1 | | 1982 | 0 | 1 | 1 | | 1984 | 0 | 3 | 3 | | 1985 | 1 | 4 | 5 | | 1986 | 0 | 6 | 6 | | 1987 | 0 | 4 | 4 | | 1988 | 0 | 4 | 4 | | 1989 | 1 | 6 | 7 | | 1990 | 0 | 3 | 3 | | 1991 | 3 | 2 | 5 | | 1992 | 1 | 3 | 4 | | 1993 | 0 | 8 | 8 | | 1994 | 0 | 5 | 5 | | 1995 | 1 | 4 | 5 | | 1996 | 1 | 13 | 14 | | 1997 | 0 | 6 | 6 | | 1998 | 0 | 7 | 7 | | 1999 | 0 | 10 | 10 | | 2000 | 1 | 17 | 18 | | 2001 | 1 | 19 | 20 | | 2002 | 3 | 23 | 26 | | 2003 | 0 | 19 | 19 | | 2004 | 3 | 28 | 31 | | 2005 | 2 | 24 | 26 | | 2006 | 2 | 28 | 30 | | 2007 | 0 | 24 | 24 | | 2008 | 2 | 37 | 39 | | 2009 | 6 | 42 | 48 | | 2010 | 2 | 41 | 43 | | 2011 | 2 | 38 | 40 | | 2012 | 0 | 44 | 44 | | 2013 | 0 | 45 | 45 | | 2014 | 1 | 45 | 46 | | 2015 | 1 | 39 | 40 | | 2016 | 0 | 25 | 25 | | 2017 | 0 | 11 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Survival" by people in Profiles.
-
Foley LS, Fullerton DA, Mares J, Sungelo M, Weyant MJ, Cleveland JC, Reece TB. Erythropoietin's Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons. Ann Thorac Surg. 2017 Dec; 104(6):1909-1914.
-
Kumar R, Deep G, Wempe MF, Surek J, Kumar A, Agarwal R, Agarwal C. Procyanidin B2 3,3?-di-O-gallate induces oxidative stress-mediated cell death in prostate cancer cells via inhibiting MAP kinase phosphatase activity and activating ERK1/2 and AMPK. Mol Carcinog. 2018 Jan; 57(1):57-69.
-
Pecaut MJ, Mao XW, Bellinger DL, Jonscher KR, Stodieck LS, Ferguson VL, Bateman TA, Mohney RP, Gridley DS. Is spaceflight-induced immune dysfunction linked to systemic changes in metabolism? PLoS One. 2017; 12(5):e0174174.
-
Caldwell AS, Campbell GT, Shekiro KMT, Anseth KS. Clickable Microgel Scaffolds as Platforms for 3D Cell Encapsulation. Adv Healthc Mater. 2017 Aug; 6(15).
-
Cummings CS, Fein K, Murata H, Ball RL, Russell AJ, Whitehead KA. ATRP-grown protein-polymer conjugates containing phenylpiperazine selectively enhance transepithelial protein transport. J Control Release. 2017 Jun 10; 255:270-278.
-
Carey A, Edwards DK, Eide CA, Newell L, Traer E, Medeiros BC, Pollyea DA, Deininger MW, Collins RH, Tyner JW, Druker BJ, Bagby GC, McWeeney SK, Agarwal A. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. Cell Rep. 2017 Mar 28; 18(13):3204-3218.
-
Smith CE, Soti S, Jones TA, Nakagawa A, Xue D, Yin H. Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors. Cell Chem Biol. 2017 Mar 16; 24(3):281-292.
-
Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature. 2017 03 09; 543(7644):252-256.
-
Dimberg LY, Towers CG, Behbakht K, Hotz TJ, Kim J, Fosmire S, Porter CC, Tan AC, Thorburn A, Ford HL. A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance. Mol Cancer Res. 2017 Apr; 15(4):382-394.
-
Mulcahy Levy JM, Zahedi S, Griesinger AM, Morin A, Davies KD, Aisner DL, Kleinschmidt-DeMasters BK, Fitzwalter BE, Goodall ML, Thorburn J, Amani V, Donson AM, Birks DK, Mirsky DM, Hankinson TC, Handler MH, Green AL, Vibhakar R, Foreman NK, Thorburn A. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. Elife. 2017 01 17; 6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|